GlassScriptPhysician profile
Angel Cho
NPI 1720152754
$15,252.90
in general payments reported to CMS, 2019-2025
30 companies · $894 in 2025
The $894 reported for 2025 was more than what 89% of Obstetrics & Gynecology providers received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,572 · 2020: $5,138 · 2021: $212 · 2022: $5,414 · 2023: $1,653 · 2024: $370 · 2025: $894.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,633 · Education: $284.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,633.07 |
| Education | $283.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $5,235.60 | 2020-2022 | |
| Shield Therapeutics INC | $4,284.08 | 2022-2023 | Accrufer |
| Asensus Surgical, INC. | $872.33 | 2019 | |
| Acessa Health INC. | $629.37 | 2022 | |
| Hologic Sales and Service, LLC | $621.71 | 2022-2025 | Acessa Provu System, Fluent Fluid Management System, Myosure Tissue Removal Device |
| Astellas Pharma US INC | $594.80 | 2023-2025 | Veozah |
| Coopersurgical, INC. | $395.03 | 2019-2025 | Advincula Delineator Uterine Manipulator, Ally II Ups, Endosee |
| Therapeuticsmd, INC. | $247.02 | 2019 | |
| Medtronic, INC. | $234.63 | 2021-2025 | V-Loc 180 |
| Pfizer INC. | $225.87 | 2024-2025 | |
| Sumitomo Pharma America, INC. | $199.36 | 2023-2025 | Myfembree |
| Amgen INC. | $187.16 | 2019 | |
| Evofem Biosciences, INC. | $178.10 | 2021-2025 | Phexxi, Solosec, Phexx |
| Gynesonics, INC. | $176.84 | 2023-2024 | Sonata Sonography-Guided Transcervical Fibroid Ablation System |
| Conmed Corporation | $162.45 | 2021 |
Show all 30 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ethicon US, LLC | $142.38 | 2019-2020 | |
| Abbvie INC. | $125.49 | 2019-2023 | Orilissa, Lo Loestrin Fe |
| Exeltis, USA INC. | $125.26 | 2023-2025 | Slynd |
| Baxter Healthcare | $118.83 | 2023 | Floseal |
| Aspira Women'S Health INC | $118.56 | 2019-2024 | Ova1 |
| Bayer Healthcare Pharmaceuticals INC. | $72.08 | 2019-2023 | |
| Myovant Sciences INC. | $62.61 | 2022 | |
| Avion Pharmaceuticals | $52.07 | 2023 | Balcoltra |
| Sage Therapeutics, LLC | $49.75 | 2023-2024 | |
| Applied Medical Resources Corporation | $41.65 | 2023 | Gelpoint V-Path |
| Biogen, INC. | $26.74 | 2024 | Zurzuvae |
| Meditrina | $20.58 | 2023 | |
| Organon LLC | $18.85 | 2023 | Nexplanon |
| Merck Sharp & Dohme LLC | $17.68 | 2020 | |
| Convatec INC. | $16.02 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Angel Cho listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.